Gene · 55872
Papers1,726
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,726
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Differentially Expressed Genes Associated with the Prognosis and Diagnosis of Hepatocellular Carcinoma by Integrated Bioinformatics Analysis. | Biomed Res Int | 2022 | 36317111 | PubTator, text mining | PubMed |
| Research progress of ginseng in the treatment of gastrointestinal cancers. | Front Pharmacol | 2022 | 36313365 | PubTator, text mining | PubMed |
| ASPM May be Related to the Malignant Progression of Hepatitis B and is Associated With a Poor Prognosis of Hepatocellular Carcinoma. | Front Bioinform | 2022 | 36304312 | PubTator, text mining | PubMed |
| Cleaning the Label of Cured Meat; Effect of the Replacement of Nitrates/Nitrites on Nutrients Bioaccessibility, Peptides Formation, and Cellular Toxicity of In Vitro Digested Salami. | Int J Mol Sci | 2022 | 36293416 | PubTator, text mining | PubMed |
| Role of Cell-Cell Junctions in Oesophageal Squamous Cell Carcinoma. | Biomolecules | 2022 | 36291586 | PubTator, text mining | PubMed |
| Therapeutic Strategies for Restoring Perturbed Corneal Epithelial Homeostasis in Limbal Stem Cell Deficiency: Current Trends and Future Directions. | Cells | 2022 | 36291115 | PubTator, text mining | PubMed |
| Quantitative Proteomic Analysis of Zearalenone-Induced Intestinal Damage in Weaned Piglets. | Toxins (Basel) | 2022 | 36287972 | PubTator, text mining | PubMed |
| Dopachrome tautomerase is a retinoblastoma-specific gene, and its proximal promoter is preferentially active in human retinoblastoma cells. | Mol Vis | 2022 | 36274817 | PubTator, text mining | PubMed |
| A BDNF-TrkB autocrine loop enhances senescent cell viability. | Nat Commun | 2022 | 36266274 | PubTator, text mining | PubMed |
| NXPH4 Used as a New Prognostic and Immunotherapeutic Marker for Muscle-Invasive Bladder Cancer. | J Oncol | 2022 | 36245981 | PubTator, text mining | PubMed |
| Identification of core genes as potential biomarkers for predicting progression and prognosis in glioblastoma. | Front Genet | 2022 | 36238156 | PubTator, text mining | PubMed |
| Female Germ Cell Development in Chickens and Humans: The Chicken Oocyte Enriched Genes Convergent and Divergent with the Human Oocyte. | Int J Mol Sci | 2022 | 36232712 | PubTator, text mining | PubMed |
| Identification of biomarkers related to tumorigenesis and prognosis in breast cancer. | Gland Surg | 2022 | 36221277 | PubTator, text mining | PubMed |
| Epigenetic factors in breast cancer therapy. | Front Genet | 2022 | 36212140 | PubTator, text mining | PubMed |
| Bioinformatics and network-based screening and discovery of potential molecular targets and small molecular drugs for breast cancer. | Front Pharmacol | 2022 | 36204232 | PubTator, text mining | PubMed |
| Analysis and identification of potential type II helper T cell (Th2)-Related key genes and therapeutic agents for COVID-19. | Comput Biol Med | 2022 | 36201886 | PubTator, text mining | PubMed |
| Bioinformatic identification of differentially expressed genes associated with hepatocellular carcinoma prognosis. | Medicine (Baltimore) | 2022 | 36197270 | PubTator, text mining | PubMed |
| HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans. | Clin Cancer Res | 2022 | 36190432 | PubTator, text mining | PubMed |
| Dissecting novel mechanisms of hepatitis B virus related hepatocellular carcinoma using meta-analysis of public data. | World J Gastrointest Oncol | 2022 | 36187396 | PubTator, text mining | PubMed |
| A comprehensive analysis of G-protein-signaling modulator 2 as a prognostic and diagnostic marker for pan-cancer. | Front Genet | 2022 | 36186420 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55872/papers?page=20